Treatment decisions regarding caries and dental developmental defects in children - a questionnaire-based study among Norwegian dentists.


Journal

BMC oral health
ISSN: 1472-6831
Titre abrégé: BMC Oral Health
Pays: England
ID NLM: 101088684

Informations de publication

Date de publication:
10 05 2019
Historique:
received: 20 12 2018
accepted: 24 03 2019
entrez: 12 5 2019
pubmed: 12 5 2019
medline: 20 11 2019
Statut: epublish

Résumé

Current knowledge on treatment strategies and choice of restorative materials when treating deep caries or severe dental developmental defects (DDDs) in young individuals is scarce. Therefore, the aim was to investigate Norwegian dentists´ treatment decisions and reasons for treatment choice when treating deep caries in primary teeth and severe DDDs in permanent teeth in children. A pre-coded questionnaire was sent electronically to all dentists employed in the Public Dental Service (PDS) in Norway (n = 1294). The clinicians were asked about their background characteristics and how often they registered DDDs. Three clinical cases were presented to the dentists and asked to prioritize treatment options and reasons for their choice. After three reminders, 45.8% of the dentists answered. Most clinicians were general practitioners (96.3%), females (77.9%), under 41 year-olds (59.4%), graduated in 2001 or later (61.1%), and representing all regions of Norway. The respondents registered molar incisor hypomineralisation (MIH), other DDDs and dental fluorosis (DF) frequently, 523 (91.1%), 257 (44.8%) and 158 (27.5%), respectively. In case 1a with severe dental caries in a primary molar, the preferred treatment was resin-modified glass ionomer cement (RMGIC) (58.3%), followed by glass ionomer cement (GIC) (17.9%) and zinc oxide-eugenol (ZOE) (13.2%). Extraction, compomer or stainless steel crowns (SSC) were preferred by 0.9, 0.7 and 0.4%, respectively. In case 1b, which was identical to case 1a, but treated under general anaesthesia, the preferred treatment alternatives were RMGIC (37.1%), resin composite (RC) (17.6%) and GIC (17.2%). Extraction and SSC were chosen by 15.1 and 7.2%, respectively. In case 2, showing a severely hypomineralised and symptomatic first permanent molar, the dentists preferred RC (38.4%), followed by RMGIC (26.6%) and GIC (19.0%). Extraction and SSC were chosen by 8.7 and 5.4%, respectively. The treatment choices were not significantly affected by the dentists' background characteristics. The reasons for dentists' treatment decisions varied for each patient case; patient cooperation, prognosis of the tooth and own experience were the dominant reasons. A notable disparity in treatment choices was shown indicating that Norwegian dentists evaluate each case individually and base their decisions on what they consider best for the individual patient.

Sections du résumé

BACKGROUND
Current knowledge on treatment strategies and choice of restorative materials when treating deep caries or severe dental developmental defects (DDDs) in young individuals is scarce. Therefore, the aim was to investigate Norwegian dentists´ treatment decisions and reasons for treatment choice when treating deep caries in primary teeth and severe DDDs in permanent teeth in children.
METHODS
A pre-coded questionnaire was sent electronically to all dentists employed in the Public Dental Service (PDS) in Norway (n = 1294). The clinicians were asked about their background characteristics and how often they registered DDDs. Three clinical cases were presented to the dentists and asked to prioritize treatment options and reasons for their choice.
RESULTS
After three reminders, 45.8% of the dentists answered. Most clinicians were general practitioners (96.3%), females (77.9%), under 41 year-olds (59.4%), graduated in 2001 or later (61.1%), and representing all regions of Norway. The respondents registered molar incisor hypomineralisation (MIH), other DDDs and dental fluorosis (DF) frequently, 523 (91.1%), 257 (44.8%) and 158 (27.5%), respectively. In case 1a with severe dental caries in a primary molar, the preferred treatment was resin-modified glass ionomer cement (RMGIC) (58.3%), followed by glass ionomer cement (GIC) (17.9%) and zinc oxide-eugenol (ZOE) (13.2%). Extraction, compomer or stainless steel crowns (SSC) were preferred by 0.9, 0.7 and 0.4%, respectively. In case 1b, which was identical to case 1a, but treated under general anaesthesia, the preferred treatment alternatives were RMGIC (37.1%), resin composite (RC) (17.6%) and GIC (17.2%). Extraction and SSC were chosen by 15.1 and 7.2%, respectively. In case 2, showing a severely hypomineralised and symptomatic first permanent molar, the dentists preferred RC (38.4%), followed by RMGIC (26.6%) and GIC (19.0%). Extraction and SSC were chosen by 8.7 and 5.4%, respectively. The treatment choices were not significantly affected by the dentists' background characteristics. The reasons for dentists' treatment decisions varied for each patient case; patient cooperation, prognosis of the tooth and own experience were the dominant reasons.
CONCLUSIONS
A notable disparity in treatment choices was shown indicating that Norwegian dentists evaluate each case individually and base their decisions on what they consider best for the individual patient.

Identifiants

pubmed: 31077165
doi: 10.1186/s12903-019-0744-2
pii: 10.1186/s12903-019-0744-2
pmc: PMC6509767
doi:

Substances chimiques

Glass Ionomer Cements 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

80

Références

Int J Paediatr Dent. 2018 Mar;28(2):249-256
pubmed: 29205613
Pediatr Dent. 2018 Oct 15;40(6):330-342
pubmed: 32074904
Eur Arch Paediatr Dent. 2018 Jun;19(3):187-195
pubmed: 29761341
Adv Dent Res. 2016 May;28(2):58-67
pubmed: 27099358
J Clin Pediatr Dent. 2015 Summer;39(4):303-10
pubmed: 26161599
Community Dent Oral Epidemiol. 1997 Dec;25(6):396-401
pubmed: 9429811
BMC Oral Health. 2016 Jul 04;17(1):3
pubmed: 27430640
Int J Paediatr Dent. 2002 Jan;12(1):24-32
pubmed: 11853245
Cochrane Database Syst Rev. 2015 Dec 31;(12):CD005512
pubmed: 26718872
Eur J Paediatr Dent. 2003 Sep;4(3):121-6
pubmed: 14529331
Pediatr Dent. 2016 Nov 15;38(7):489-496
pubmed: 28281954
BMC Oral Health. 2018 Feb 7;18(1):20
pubmed: 29415706
Caries Res. 2004 Mar-Apr;38(2):130-41
pubmed: 14767170
Bull World Health Organ. 2005 Sep;83(9):661-9
pubmed: 16211157
J Clin Periodontol. 2017 Mar;44 Suppl 18:S94-S105
pubmed: 28266116
Pediatr Dent. 2006 May-Jun;28(3):224-32
pubmed: 16805354
Int J Paediatr Dent. 2018 Mar;28(2):123-139
pubmed: 29322626
J Am Dent Assoc. 2010 Apr;141(4):401-14
pubmed: 20354089
Eur Arch Paediatr Dent. 2010 Apr;11(2):65-74
pubmed: 20403300
Eur J Paediatr Dent. 2005 Dec;6(4):179-84
pubmed: 16426116
J Dent Res. 2015 Jan;94(1):10-8
pubmed: 25394849
Int J Public Health. 2018 Jul;63(6):765-773
pubmed: 29691594
Int J Paediatr Dent. 2007 Sep;17(5):328-35
pubmed: 17683321
Cochrane Database Syst Rev. 2009 Apr 15;(2):CD004483
pubmed: 19370602
Eur Arch Paediatr Dent. 2015 Jun;16(3):235-46
pubmed: 25916282

Auteurs

M M Uhlen (MM)

Oral Health Centre of Expertise in Eastern Norway (OHCE-E), Oslo, Norway. martemau@ostfoldfk.no.

H Valen (H)

Nordic Institute for Dental Materials (NIOM), Oslo, Norway.

L S Karlsen (LS)

Oral Health Centre of Expertise in Eastern Norway (OHCE-E), Oslo, Norway.

A B Skaare (AB)

Oral Health Centre of Expertise in Southern Norway (OHCE-S), Arendal, Norway.
Department of Paediatric Dentistry and Behavioural Science, Institute of Clinical Dentistry, University of Oslo, Oslo, Norway.

A Bletsa (A)

Oral Health Centre of Expertise in Western Norway Hordaland (OHCE-W Hordaland), Bergen, Norway.

V Ansteinsson (V)

Oral Health Centre of Expertise in Eastern Norway (OHCE-E), Oslo, Norway.

A Mulic (A)

Nordic Institute for Dental Materials (NIOM), Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH